Traws Pharma, Inc. ONTX
CBOE · stock · Pharmaceutical Preparations · website · IPO 2013-07-25
Traws Pharma, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -640.7% | -62997.3% | -8981.4% | -8684.5% | -7299.1% | -10819.5% | -994.0% | -1895.9% | -3270.3% | -427.4% |
| Net margin | 328.7% | -73682.7% | -8384.1% | -8391.2% | -7151.8% | -10890.5% | -985.0% | -1675.3% | -3061.2% | -354.6% |
| FCF margin | — | — | -7940.7% | — | — | -9995.7% | -956.8% | — | — | — |
| Return on assets | 86.4% | -667.1% | -83.5% | -48.2% | -29.1% | -125.9% | -90.8% | -114.8% | -483.9% | -84.7% |
| Return on equity | -1457.9% | 526.5% | -177.5% | -67.0% | -35.0% | -407.4% | -185.8% | -381.9% | 206.1% | -383.6% |
| Current ratio | 0.72 | 2.16 | 2.46 | 4.89 | 9.06 | 1.97 | 2.83 | 2.11 | 0.49 | 2.27 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.